电竞投注

 

甲狀腺乳腺外科

甲狀腺乳腺外科

電競(jing)下(xia)注APP平臺甲(jia)(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)(xian)乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)外(wai)科(ke)(ke)的前身是普外(wai)科(ke)(ke),目(mu)前擁有醫(yi)師(shi)22名(ming)(ming)(ming),其中(zhong)主(zhu)任(ren)(ren)醫(yi)師(shi)2名(ming)(ming)(ming),副(fu)主(zhu)任(ren)(ren)醫(yi)師(shi)2名(ming)(ming)(ming),主(zhu)治(zhi)醫(yi)師(shi)9名(ming)(ming)(ming),住院醫(yi)師(shi)9名(ming)(ming)(ming),博士(shi)生導師(shi)1名(ming)(ming)(ming),醫(yi)學(xue)博士(shi)5名(ming)(ming)(ming),碩士(shi)16名(ming)(ming)(ming)。護理人(ren)員30名(ming)(ming)(ming),其中(zhong),副(fu)主(zhu)任(ren)(ren)護師(shi)1名(ming)(ming)(ming),主(zhu)管護師(shi)11名(ming)(ming)(ming),形成(cheng)(cheng)了完整的人(ren)才梯隊體(ti)(ti)系。2009年(nian),隨(sui)(sui)著住院一部的啟用,為適應醫(yi)學(xue)發(fa)展(zhan)專業化(hua)、精細化(hua)的要(yao)求,醫(yi)院決(jue)定將普外(wai)二科(ke)(ke)更名(ming)(ming)(ming)為甲(jia)(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)(xian)乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)外(wai)科(ke)(ke),隨(sui)(sui)即科(ke)(ke)室主(zhu)任(ren)(ren)楊振(zhen)林根(gen)據(ju)醫(yi)院依托(tuo),帶領大家努力轉(zhuan)型,將科(ke)(ke)室工作重(zhong)心轉(zhuan)移到甲(jia)(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)(xian)乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)疾(ji)病。臨床上,圍(wei)繞甲(jia)(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)(xian)乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)疾(ji)病不斷開展(zhan)新技(ji)(ji)術(shu)(shu)(shu)新項(xiang)目(mu),乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)方面(mian)包(bao)括: 不改(gai)變乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)外(wai)形的多(duo)種(zhong)保(bao)乳(ru)(ru)手術(shu)(shu)(shu)(腺(xian)(xian)(xian)(xian)(xian)體(ti)(ti)肌皮瓣轉(zhuan)移、背(bei)闊肌周(zhou)圍(wei)肌筋膜轉(zhuan)移及(ji)創腔周(zhou)圍(wei)帶血管蒂轉(zhuan)移等)、乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)癌(ai)(ai)根(gen)治(zhi)術(shu)(shu)(shu)后即刻(ke)再造成(cheng)(cheng)形術(shu)(shu)(shu)(背(bei)闊肌、背(bei)闊肌聯合(he)假(jia)(jia)體(ti)(ti)再造、腹直肌自體(ti)(ti)再造、雙(shuang)平面(mian)假(jia)(jia)體(ti)(ti)再造、擴張器皮下(xia)植(zhi)入(ru)二次假(jia)(jia)體(ti)(ti)植(zhi)入(ru)再造)、常(chang)規保(bao)留(liu)胸外(wai)側及(ji)肋間壁(bi)神經(jing)的乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)癌(ai)(ai)改(gai)良根(gen)治(zhi)術(shu)(shu)(shu)、Mammotome 乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)微創手術(shu)(shu)(shu)、乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)MRI診斷隱匿性乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)癌(ai)(ai)、乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)癌(ai)(ai)前哨淋巴結活(huo)檢(jian)(常(chang)規術(shu)(shu)(shu)中(zhong)實施(shi)、彩(cai)超(chao)引導下(xia)的活(huo)檢(jian))、乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)彩(cai)超(chao)全容積成(cheng)(cheng)像技(ji)(ji)術(shu)(shu)(shu)、乳(ru)(ru)腺(xian)(xian)(xian)(xian)(xian)專用伽馬顯像技(ji)(ji)術(shu)(shu)(shu)等。近兩年(nian)結合(he)Breast Reconstruction (Oncoplastic?Surgery)理念把整形(xing)(xing)技(ji)術(shu)(shu)貫徹到(dao)乳(ru)(ru)腺(xian)(xian)(xian)(xian)良惡性(xing)疾病(bing)手術(shu)(shu)中,如巨(ju)乳(ru)(ru)雙側(ce)上提(ti)縮乳(ru)(ru)術(shu)(shu),極大提(ti)高(gao)了(le)乳(ru)(ru)腺(xian)(xian)(xian)(xian)外形(xing)(xing)術(shu)(shu)后(hou)的(de)滿(man)意度(du),200多例復雜性(xing)非哺乳(ru)(ru)期(qi)乳(ru)(ru)腺(xian)(xian)(xian)(xian)炎(yan)的(de)治(zhi)(zhi)療(liao),病(bing)人(ren)滿(man)意度(du)達到(dao)95%以(yi)上,結合(he)VSD技(ji)術(shu)(shu)大大縮短了(le)病(bing)人(ren)的(de)愈合(he)時間。重度(du)下(xia)垂乳(ru)(ru)房的(de)雙側(ce)乳(ru)(ru)腺(xian)(xian)(xian)(xian)癌NSM+乳(ru)(ru)頭(tou)乳(ru)(ru)暈上提(ti)+一(yi)期(qi)假體雙平面(mian)植入術(shu)(shu)+前(qian)哨(shao)淋(lin)巴結活(huo)檢術(shu)(shu),此(ci)手術(shu)(shu)國際報(bao)道(dao)11例;吸脂術(shu)(shu)+單孔(kong)腔(qiang)鏡下(xia)保(bao)留乳(ru)(ru)頭(tou)乳(ru)(ru)暈的(de)乳(ru)(ru)腺(xian)(xian)(xian)(xian)癌切除(chu)+背闊肌一(yi)期(qi)重建(jian)術(shu)(shu),為國內領先。近期(qi)還開展了(le)男性(xing)乳(ru)(ru)房肥大的(de)脂肪抽吸治(zhi)(zhi)療(liao)、二次(ci)乳(ru)(ru)腺(xian)(xian)(xian)(xian)整形(xing)(xing)的(de)自體脂肪移植等,均獲(huo)得了(le)滿(man)意的(de)效果。 甲(jia)(jia)狀(zhuang)(zhuang)腺(xian)(xian)(xian)(xian)方面(mian)包括(kuo): 彩超引(yin)(yin)導下(xia)定位穿刺活(huo)檢、小切口改良miccoli甲(jia)(jia)狀(zhuang)(zhuang)腺(xian)(xian)(xian)(xian)癌改良根治(zhi)(zhi)術(shu)(shu)、腔(qiang)鏡下(xia)甲(jia)(jia)狀(zhuang)(zhuang)腺(xian)(xian)(xian)(xian)癌根治(zhi)(zhi)術(shu)(shu)、3D-打(da)印巨(ju)大甲(jia)(jia)狀(zhuang)(zhuang)腺(xian)(xian)(xian)(xian)腫及(ji)甲(jia)(jia)狀(zhuang)(zhuang)旁(pang)腺(xian)(xian)(xian)(xian)定位手術(shu)(shu)、甲(jia)(jia)狀(zhuang)(zhuang)旁(pang)腺(xian)(xian)(xian)(xian)的(de)微創手術(shu)(shu)等,同(tong)時積(ji)極籌(chou)備彩超引(yin)(yin)導下(xia)的(de)甲(jia)(jia)狀(zhuang)(zhuang)腺(xian)(xian)(xian)(xian)結節微波及(ji)射頻消(xiao)融術(shu)(shu)。我科(ke)以(yi)“呵護女性(xing)健康,綻放美麗人(ren)生”為理念,竭誠為廣大患(huan)者(zhe)提(ti)供最優質的(de)醫療(liao)服務。目(mu)前(qian),我科(ke)積(ji)極籌(chou)備建(jian)設集(ji)檢查、診斷、治(zhi)(zhi)療(liao)于(yu)一(yi)體的(de)門診一(yi)體治(zhi)(zhi)療(liao)部,以(yi)便為患(huan)者(zhe)提(ti)供更加便捷、高(gao)效的(de)服務。

科(ke)(ke)研(yan)(yan)上,與(yu)臨床(chuang)科(ke)(ke)室疾(ji)病(bing)相結合,專攻乳(ru)腺(xian)(xian)及(ji)甲狀腺(xian)(xian)疾(ji)病(bing)的(de)(de)(de)(de)(de)(de)(de)科(ke)(ke)學研(yan)(yan)究(jiu)(jiu),并以(yi)此申請(qing)甲狀腺(xian)(xian)乳(ru)腺(xian)(xian)外(wai)科(ke)(ke)疾(ji)病(bing)的(de)(de)(de)(de)(de)(de)(de)課(ke)題(ti)(ti)。楊振(zhen)林博士(shi)時刻(ke)把握甲狀腺(xian)(xian)乳(ru)腺(xian)(xian)疾(ji)病(bing)研(yan)(yan)究(jiu)(jiu)領域的(de)(de)(de)(de)(de)(de)(de)科(ke)(ke)研(yan)(yan)動態(tai),關注(zhu)此領域的(de)(de)(de)(de)(de)(de)(de)前(qian)沿研(yan)(yan)究(jiu)(jiu)進展,承擔和(he)完成(cheng)多(duo)(duo)項(xiang)國(guo)(guo)(guo)(guo)家(jia)自然科(ke)(ke)學基(ji)金、省(sheng)部(bu)級和(he)校級科(ke)(ke)研(yan)(yan)項(xiang)目(mu),包括國(guo)(guo)(guo)(guo)家(jia)自然科(ke)(ke)學基(ji)金課(ke)題(ti)(ti)《補骨脂(zhi)制劑及(ji)其主(zhu)要單(dan)體(ti)逆(ni)轉乳(ru)腺(xian)(xian)癌(ai)(ai)(ai)干細(xi)胞(bao)(bao)多(duo)(duo)藥(yao)(yao)(yao)耐藥(yao)(yao)(yao)的(de)(de)(de)(de)(de)(de)(de)實驗(yan)研(yan)(yan)究(jiu)(jiu)》、《誘導(dao)乳(ru)腺(xian)(xian)癌(ai)(ai)(ai)干細(xi)胞(bao)(bao)分化(hua)并實施化(hua)療(liao)的(de)(de)(de)(de)(de)(de)(de)實驗(yan)研(yan)(yan)究(jiu)(jiu)》,衛生部(bu)課(ke)題(ti)(ti)《熒光原位雜交(jiao)技(ji)(ji)(ji)術在(zai)產前(qian)遺傳性(xing)疾(ji)病(bing)及(ji)部(bu)分腫瘤檢測(ce)的(de)(de)(de)(de)(de)(de)(de)多(duo)(duo)中心臨床(chuang)應(ying)用研(yan)(yan)究(jiu)(jiu)》,國(guo)(guo)(guo)(guo)家(jia)衛生部(bu)專項(xiang)基(ji)金《連續性(xing)血液凈化(hua)(CBP)在(zai)治(zhi)療(liao)腹腔間(jian)隔室綜(zong)合癥(ACS)中的(de)(de)(de)(de)(de)(de)(de)應(ying)用》,國(guo)(guo)(guo)(guo)家(jia)衛生部(bu)重點項(xiang)目(mu)《乳(ru)腺(xian)(xian)癌(ai)(ai)(ai)高危人群篩選及(ji)評估體(ti)系的(de)(de)(de)(de)(de)(de)(de)建(jian)立與(yu)完善》,山(shan)東省(sheng)自然科(ke)(ke)學基(ji)金《整(zheng)合素αvβ6及(ji)其靶向5-FU脂(zhi)質體(ti)在(zai)結腸癌(ai)(ai)(ai)化(hua)療(liao)耐藥(yao)(yao)(yao)中的(de)(de)(de)(de)(de)(de)(de)作用》、《Sorafenib防止肝癌(ai)(ai)(ai)肝移(yi)植后(hou)術后(hou)復發(fa)的(de)(de)(de)(de)(de)(de)(de)研(yan)(yan)究(jiu)(jiu)》、《乳(ru)腺(xian)(xian)原發(fa)癌(ai)(ai)(ai)和(he)淋巴結轉移(yi)癌(ai)(ai)(ai)干細(xi)胞(bao)(bao)分離及(ji)其信號通(tong)路分子(zi)的(de)(de)(de)(de)(de)(de)(de)比較(jiao)研(yan)(yan)究(jiu)(jiu)》、《超聲光散(san)射聯合彈(dan)性(xing)成(cheng)像技(ji)(ji)(ji)術診斷乳(ru)腺(xian)(xian)腫瘤》,山(shan)東省(sheng)醫(yi)藥(yao)(yao)(yao)衛生科(ke)(ke)技(ji)(ji)(ji)發(fa)展計劃《乳(ru)腺(xian)(xian)癌(ai)(ai)(ai)干細(xi)胞(bao)(bao)分離鑒定(ding)和(he)耐藥(yao)(yao)(yao)情況的(de)(de)(de)(de)(de)(de)(de)研(yan)(yan)究(jiu)(jiu)》,山(shan)東省(sheng)高等(deng)(deng)學校科(ke)(ke)技(ji)(ji)(ji)計劃項(xiang)目(mu)《組織型(xing)轉谷氨酰胺酶介導(dao)乳(ru)腺(xian)(xian)癌(ai)(ai)(ai)干細(xi)胞(bao)(bao)多(duo)(duo)藥(yao)(yao)(yao)耐藥(yao)(yao)(yao)機制的(de)(de)(de)(de)(de)(de)(de)實驗(yan)研(yan)(yan)究(jiu)(jiu)》等(deng)(deng)課(ke)題(ti)(ti)。科(ke)(ke)室總的(de)(de)(de)(de)(de)(de)(de)科(ke)(ke)研(yan)(yan)經費超過200多(duo)(duo)萬元。培養醫(yi)學博士(shi)(在(zai)職)5名,醫(yi)學碩士(shi)16名。主(zhu)編著(zhu)作1部(bu),參編著(zhu)作1部(bu),在(zai)國(guo)(guo)(guo)(guo)內外(wai)期刊上發(fa)表論文60余篇(pian)。其中以(yi)SCI收錄文獻(xian)15篇(pian),單(dan)篇(pian)SCI影(ying)(ying)響因(yin)子(zi)最高5.2,累(lei)計影(ying)(ying)響因(yin)子(zi)達32。

目(mu)前(qian)電競下注(zhu)APP平臺甲狀腺(xian)乳腺(xian)外科(ke)是魯北地區集臨(lin)床、教學、科(ke)研于一體的(de)甲狀腺(xian)乳腺(xian)疾病診療中(zhong)心,為全國乳腺(xian)癌臨(lin)床數據(ju)協助(zhu)組單位、中(zhong)國乳腺(xian)微(wei)創與腔鏡手(shou)術聯(lian)盟成員單位、山(shan)(shan)東(dong)省區域(yu)乳腺(xian)中(zhong)心聯(lian)盟分(fen)中(zhong)心,山(shan)(shan)東(dong)省青年(nian)文明號科(ke)室、山(shan)(shan)東(dong)省臨(lin)床重(zhong)(zhong)點(dian)專(zhuan)(zhuan)科(ke)、濱(bin)州醫學院(yuan)重(zhong)(zhong)點(dian)科(ke)室、濱(bin)州醫學院(yuan)創新團隊、電競投注(zhu)臨(lin)床重(zhong)(zhong)點(dian)專(zhuan)(zhuan)科(ke),連年(nian)獲得患者最滿(man)意科(ke)室。

】【打印關閉】 【返回頂部